Development of the pharmaceutical service for the replacement of chronic therapy, which consists of the activation of prescription lines by the physician, with a pre-established period, allowing the pharmacist to dispense medicines prescribed for chronic diseases continuously.

Development of intervention protocols that support the therapy replacement service and ensure that the pharmacist assesses the evolution of the disease burden, the existence of contraindications and serious interactions, as well as signs or symptoms or any other situation that makes renewal inadvisable and suggests referral via the “direct referral line” and the scheduling of consultations with the physician for the most urgent problems.

Implementation of a defined and contractualised model between the NHS and pharmacies for pharmaceutical support in disease management and replacement of therapy, which could start with chronic diseases that require more active monitoring and surveillance.